Receptor for advanced glycation end products and soluble receptor for advanced glycation end products: a balancing act in chronic obstructive pulmonary disease? (Q54757715)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Receptor for advanced glycation end products and soluble receptor for advanced glycation end products: a balancing act in chronic obstructive pulmonary disease?	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24127795

0 references

Receptor for advanced glycation end products and soluble receptor for advanced glycation end products: a balancing act in chronic obstructive pulmonary disease? (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24127795

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

Maria B. Sukkar

1

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24127795

2

object named as

Dirkje S Postma

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24127795

language of work or name

0 references

publication date

1 October 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24127795

American Journal of Respiratory and Critical Care Medicine

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24127795

188

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24127795

8

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24127795

893-894

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24127795

RAGE: a new frontier in chronic airways disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201308-1489ED

21 January 2018

RAGE and tobacco smoke: insights into modeling chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201308-1489ED

21 January 2018

Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201308-1489ED

21 January 2018

Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201308-1489ED

21 January 2018

The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201308-1489ED

21 January 2018

Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201308-1489ED

21 January 2018

Conditional overexpression of receptors for advanced glycation end-products in the adult murine lung causes airspace enlargement and induces inflammation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201308-1489ED

21 January 2018

Receptor for advanced glycation end products contributes to postnatal pulmonary development and adult lung maintenance program in mice.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201308-1489ED

21 January 2018

Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201308-1489ED

21 January 2018

Genome-wide association study identifies five loci associated with lung function

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201308-1489ED

21 January 2018

Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201308-1489ED

21 January 2018

CHRNA3/5, IREB2, and ADCY2 are associated with severe chronic obstructive pulmonary disease in Poland

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201308-1489ED

21 January 2018

Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201308-1489ED

21 January 2018

The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201308-1489ED

21 January 2018

Does RAGE protect smokers from COPD?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201308-1489ED

21 January 2018

Identifiers

10.1164/RCCM.201308-1489ED

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24127795

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24127795

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54757715&oldid=1209831141"